Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000172119 | SCV000051058 | uncertain significance | not provided | 2013-06-24 | criteria provided, single submitter | research | |
Laboratory for Molecular Medicine, |
RCV000152048 | SCV000200641 | uncertain significance | not specified | 2015-03-12 | criteria provided, single submitter | clinical testing | Variant classified as Uncertain Significance - Favor Benign. The p.Val108Ala var iant in TMEM43 has been identified in 1 Asian individual with HCM, who carried a pathogenic variant in a different HCM gene (LMM unpublished data). It has also been identified in 0.2% (19/8584) of East Asian chromosomes by the Exome Aggreg ation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs182351748). Comp utational prediction tools and conservation analysis do not provide strong suppo rt for or against an impact to the protein. In summary, while the clinical signi ficance of the p.Val108Ala variant is uncertain, its frequency suggests that it is more likely to be benign. |
Gene |
RCV000172119 | SCV000236444 | uncertain significance | not provided | 2019-08-14 | criteria provided, single submitter | clinical testing | Reported in association with sudden arrhythmogenic death syndrome (SADS) and primary electric disease (PED) (Hata et al., 2016; Proost et al., 2017); Also reported in one individual from a cohort of individuals not selected for cardiomyopathy, arrhythmia, or family history of sudden cardiac death, who underwent exome sequencing (Ng et al., 2013); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 23861362, 27005929, 28341588) |
Color Diagnostics, |
RCV001176806 | SCV001340863 | likely benign | Cardiomyopathy | 2018-12-02 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001482753 | SCV001687129 | likely benign | Arrhythmogenic right ventricular dysplasia 5 | 2023-11-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002444627 | SCV002611782 | benign | Cardiovascular phenotype | 2021-07-13 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000152048 | SCV002766458 | likely benign | not specified | 2022-11-10 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003895044 | SCV004715813 | likely benign | TMEM43-related condition | 2022-05-04 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |